Huons Co., Ltd. (243070.KQ) Stock

243070.KQ logo

Huons Co., Ltd.

243070.KQSouth Korea
Healthcare

Company profile

Huons reported revenue of 620.77 billion KRW for fiscal year 2025, up 5.2% from fiscal year 2024, and net income of 42.66 billion KRW. That is a net profit margin of 6.9% for fiscal year 2025. In Q1 2026 (the quarter ended March 31, 2026) revenue was 141.87 billion KRW, down 2.7% from a year before. South Korea was its largest region in fiscal year 2024, with 91% of revenue. In Q1 2026 it reported net income of 339.33 million KRW, against net income of 12.31 billion KRW a year earlier. Our analysis of its filings shows revenue growing from 552.01 billion KRW in fiscal year 2023 to 620.77 billion KRW in fiscal year 2025, 6.0% a year on average. Huons reports about 1,149 full-time employees.

What stands out

  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2025.

About Huons Co., Ltd.

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices. The company was formerly known as Kwang Myung Pharm and changed its name to Huons Co., Ltd. in June 2003. Huons Co., Ltd. was founded in 1965 and is headquartered in Seongnam-si, South Korea.

Largest shareholders

  • Huons Global Co., Ltd.40.74%
  • In-Sang Yoon3.378 %3.38%
  • Huons Co., Ltd.2.74%
  • Yeon-sang Yoon0.3256 %0.33%
  • Hee-sang Yoon0.3246 %0.32%

Share of the company, as of September 25, 2026

Leadership

  • SuYeong Song — CEO & Representative Director, 62
  • SinWon Kang — Chief Financial Officer, 53
  • Jung-hun Kim — Chief Disclosure Officer
  • Heonwook Park — Managing Director of Marketing, 48
  • Hosoon Chung — Managing Director of Marketing, 54

How much revenue does Huons make?

Huons reported 620.77 billion KRW in revenue for fiscal year 2025, up 5.2% from 590.23 billion KRW in fiscal year 2024. In Q1 2026 revenue was 141.87 billion KRW.

Where does Huons make most of its revenue?

South Korea: 91% of revenue by region in fiscal year 2024, followed by Export (9%).

What companies are similar to Huons?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Union Korea Pharm Co., Ltd. (080720.KQ), Samjin Pharmaceuticals Co., Ltd. (005500.KS), Hyundai Pharmaceutical Co., Ltd. (004310.KS), Reyon Pharmaceutical Co., Ltd. (102460.KS).

How has Huons' revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 436.91 billion KRW; FY2022, 492.39 billion KRW; FY2023, 552.01 billion KRW; FY2024, 590.23 billion KRW; FY2025, 620.77 billion KRW.

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Employees1,149
HeadquartersSeongnam-si, South Korea
ExchangeKOSDAQ
TimezoneAsia/Seoul (KST)

Contact & Links

Address
HuonsGlobal Bldg, Seongnam-si
Phone
82 2 854 4700
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Huons Co., Ltd. (243070.KQ)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/243070.KQ

LinkedInLinkedInXXYouTubeYouTube